Professional
Added to YB: 2025-09-26
Pitch date: 2025-09-24
NOVT [neutral]
Novanta Inc.
+14.86%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally.
Market Cap
$3.7B
Pitch Price
$103.56
Price Target
N/A
Dividend
N/A
EV/EBITDA
21.40
P/E
71.08
EV/Sales
4.30
Sector
Electronic Equipment, Instruments and Components
Category
N/A
Pernas Research Passes On: Novanta Inc.
NOVT pass: $3.9B precision photonics/vision/motion tech co for medical/industrial systems. EV/EBITDA 24x. Struggles vs pure-play leaders IPG (lasers) & Cognex (vision) with greater scale. Limited to niche apps too small for larger players, constraining long-term growth.
Read full article (1 min)